D
Drugs Made In America Acquisition II Corp. — Investor Relations & Filings
Filings indexed
31
across all filing types
Latest filing
2026-04-28
Regulatory Filings
Country
US
United States of America
Listing
US
DMIIU
Drugs Made In America Acquisition II Corp. is a blank check company, also known as a special purpose acquisition company (SPAC). It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company intends to focus its search for a business combination target within the pharmaceutical industry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | |
| 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | |
| 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | |
| QUARTERLY REPORT | 2025-11-18 | English | |
| CURRENT REPORT | 2025-11-17 | English | |
| NOTIFICATION OF LATE FILING | 2025-11-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 38191773 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-28 | English | ||
| 34607228 | 10-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-15 | English | ||
| 33302543 | 8-K - Drugs Made In America Acquisition II Corp. (0002040475) (Filer) | 2026-04-03 | English | ||
|
2025
12 filings
| |||||
| 13718380 | QUARTERLY REPORT | 2025-11-18 | English | ||
| 13718383 | CURRENT REPORT | 2025-11-17 | English | ||
| 13718381 | NOTIFICATION OF LATE FILING | 2025-11-14 | English | ||
| 13718382 | Director's Dealing 2025 | 2025-10-17 | English | ||
| 13718384 | CURRENT REPORT | 2025-10-02 | English | ||
| 13718385 | Director's Dealing 2025 | 2025-10-02 | English | ||
| 13718386 | Major Shareholding Notification 2025 | 2025-10-02 | English | ||
| 13718387 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718388 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718389 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718390 | Director's Dealing 2025 | 2025-10-01 | English | ||
| 13718391 | CURRENT REPORT | 2025-09-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Activities of non-money market investments funds
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
029 Group SE
Global investment platform for the hospitality and lifestyl…
|
Z29 | DE | Financial and insurance activit… |
|
21Shares Ethereum ETF
An ETF holding spot ether to track its performance, with po…
|
TETH | US | Financial and insurance activit… |
|
2invest AG
An investment company focusing on biotech, life science, an…
|
2INV | DE | Financial and insurance activit… |
|
3i Group PLC
An international investment company focused on Private Equi…
|
III | GB | Financial and insurance activit… |
|
3i Infrastructure PLC
Manages mid-market infrastructure assets in developed marke…
|
3IN | JE | Financial and insurance activit… |
|
450 PLC
An acquisition vehicle acquiring businesses in creative, e-…
|
450 | JE | Financial and insurance activit… |
|
49 North Resources Inc.
A venture capital firm specializing in seed and early-stage…
|
FNR | CA | Financial and insurance activit… |
|
4Aim SICAF
An investment fund investing in listed or pre-listing SMEs,…
|
AIM | IT | Financial and insurance activit… |
|
AAPKI Ventures Inc.
Diversified investment corporation and VC firm focused on e…
|
APKI | CA | Financial and insurance activit… |
|
Abacus Global Management, Inc.
An alternative asset manager specializing in life insurance…
|
ABL | US | Financial and insurance activit… |
Drugs Made In America Acquisition II Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35620/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35620 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35620 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35620 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35620}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Drugs Made In America Acquisition II Corp. (id: 35620)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.